Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
McKinsey
Harvard Business School
Express Scripts
Mallinckrodt

Last Updated: January 18, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for SB-705498

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for SB-705498?

SB-705498 is an investigational drug.

There have been 9 clinical trials for SB-705498. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2006.

The most common disease conditions in clinical trials are Rhinitis, Migraine Disorders, and Common Cold. The leading clinical trial sponsors are GlaxoSmithKline and [disabled in preview].

Recent Clinical Trials for SB-705498
TitleSponsorPhase
Intranasal SB-705498 in Allergic Rhinitis (AR) PatientsGlaxoSmithKlinePhase 2
A Study to Investigate the Effect of SB-705498 on Chronic CoughGlaxoSmithKlinePhase 2
SB705498 Proof of Concept Chamber Challenge in Subjects With Non Allergic RhinitisGlaxoSmithKlinePhase 2

See all SB-705498 clinical trials

Clinical Trial Summary for SB-705498

Top disease conditions for SB-705498
Top clinical trial sponsors for SB-705498

See all SB-705498 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
AstraZeneca
Harvard Business School
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.